LT
Linnaeus Therapeutics, Inc.
SEC filingBiotechnology · Haddonfield, NJ
Amount raised$5Msold at filing
Total offering$10M$5M still open
Investors in the raise26count reported to the SEC
FiledApr 2, 2026first sale Feb 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
James DemetriadesDirector
Chris ArendtDirector
Todd ThomsonDirector
Patrick MooneyExecutive Officer, Director
John LeppingDirector
Michael PoiselDirector
Executive officers, directors and promoters as listed on the Form D.